Growth stocks, particularly those in the biotech sector, can be lucrative long-term investments. The biotech sector often ...

Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the ...

Apogee's APG808 cut key asthma biomarker FeNO by 53% at 12 weeks with no severe adverse events, showing potential for ...

众所周知，国际化一度是Biotech的核心议题。 从跨国开展多中心临床试验，到将产品卖向全球市场，生物制药行业的成功，某种意义上正是取决于无缝衔接的国际化运作。

Investing.com — Moleculin Biotech, Inc. (NASDAQ:MBRX)是一家市值为1483万美元、当前股价为1.05美元的制药公司，该公司宣布因缺乏法定人数而取消其股东特别会议。根据InvestingPro数据显示，该公司股票在过去一年中下跌了近79%。该会议原定于2025年4月9日举行，经过两次延期后，最终定于2025年5月9日在该公司位于德克萨斯州休斯顿的总 ...

Iovance Biotherapeutics stock was tumbling Friday after the oncology drug maker posted a wider-than-expected first-quarter ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

Investing.com — Northway Biotech，一家专注于生物制药的合同开发和生产组织 (CDMO)，宣布推出其新的病毒清除研究 (VCS)能力。这一新增服务是公司战略扩张的一部分，旨在增强其在蛋白质和基因治疗板块的服务产品。

Iovance interim president and CEO Frederick Vogt blamed the lower-than-expected Q1 revenue on "a significant reduction in ...

Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.